Articles published by 2seventy bio

2seventy bio to Participate in the 2024 Morgan Stanley Global Healthcare Conference

August 29, 2024

Tickers TSVT

2seventy bio and JW Therapeutics Announce Intent To Expand Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies and Autoimmune Therapies

September 12, 2023

From 2seventy bio

Via Business Wire

Tickers TSVT

2seventy bio to Participate in 2023 Wedbush PacGrow Healthcare Conference

August 01, 2023

From 2seventy bio

Via Business Wire

Tickers TSVT

2seventy bio Presents Late-Breaking Results for SC-DARIC33, an Investigational CD33-Targeting CAR T in Pediatric and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia

May 19, 2023

From 2seventy bio

Via Business Wire

Tickers TSVT

2seventy bio to Present New Preclinical and Clinical Data from Broad Portfolio of Investigational Cell Therapies at the ASGCT 26th Annual Meeting

May 02, 2023

From 2seventy bio

Via Business Wire

Tickers TSVT

2seventy bio and Novo Nordisk Collaboration Delivers Key Proof of Concept Data, Triggering $15 Million Preclinical Milestone in In Vivo Gene Editing Hemophilia A Program

May 01, 2023

From 2seventy bio

Via Business Wire

Tickers TSVT

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.